United States government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalised with Covid-19 because it doesn't seem to be helping them.Independent monitors had paused enrollment...
Full ArticleCovid-19 coronavirus: Lilly antibody drug fails in study, others go on
New Zealand Herald
0 shares
1 views
You might like
Related news coverage
Eli Lilly Pulls The Plug On Antibody Study
Newsy
Watch VideoAn antibody treatment study from Eli Lilly is officially over.
The National Institute of Allergy and..
-
The Latest: Australia to spend on vaccines for wider region
SeattlePI.com
-
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
-
2nd study testing a COVID-19 antibody drug has a setback
SeattlePI.com
-
NA Proactive news snapshot: American Resources, MagicMed Industries, AIM ImmunoTech, Water Tower Research, Genprex UPDATE ...
Proactive Investors
Advertisement
More coverage
Lilly antibody drug fails in a COVID-19 study; others go on
Hindu
The National Institute of Allergy and Infectious Diseases said a closer look did not verify a safety problem but found a low chance..
-
Lilly antibody drug fails in a COVID-19 study; others go on
SeattlePI.com
-
AstraZeneca resuming US testing of COVID-19 vaccine
SeattlePI.com
-
Tetra Bio-Pharma inks research deal to study ARDS-003 in coronavirus animal model
Proactive Investors
-
NA Proactive news snapshot: American Resources, Bioasis Technologies, ION Energy, Melkior Resources UPDATE …
Proactive Investors